Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Market Closed
Updated:
May 6, 2024
Immunoprecise Antibodies Ltd
Cash from Investing Activities
|
Immunoprecise Antibodies Ltd
Cash from Investing Activities Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Cash from Investing Activities
-CA$2.5m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Cash from Investing Activities
-$221.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-111%
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovotech Inc
XTSX:IOT
|
Cash from Investing Activities
-CA$58.4k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-19%
|
See Also
What is Immunoprecise Antibodies Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.5m
CAD
-2.5m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Cash from Investing Activities amounts to -2.5m CAD.
What is Immunoprecise Antibodies Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
30%
30%
Over the last year, the Cash from Investing Activities growth was -56%. The average annual Cash from Investing Activities growth rates for Immunoprecise Antibodies Ltd have been 30% over the past three years .
You don't have any saved screeners yet
